Radiotherapy for ocular tumours

Eye (Basingstoke)

Volumn 27, Issue 2, 2013, Pages 119-127

  Stannard, C ^a   Sauerwein, W ^b   Maree, G ^a   Lecuona, K ^a  

^a UNIVERSITY OF CAPE TOWN   (South Africa)

^b UNIVERSITY HOSPITAL ESSEN   (Germany)

Author keywords

Brachytherapy; Iodine 125; Ocular tumours; Proton therapy; Radiotherapy

Indexed keywords

COBALT 60; IODINE 125; IRIDIUM 192; PALLADIUM 103; RUTHENIUM 106; STRONTIUM 90;

BRACHYTHERAPY; CANCER RADIOTHERAPY; CONFERENCE PAPER; CONJUNCTIVA; CONJUNCTIVA TUMOR; CONTACT LENS; CRYOTHERAPY; DOSIMETRY; ELECTROMAGNETIC RADIATION; EXTERNAL BEAM RADIOTHERAPY; EYE TUMOR; HUMAN; IONIZING RADIATION; LIFE EXPECTANCY; LOW ENERGY RADIATION; MARGINAL ZONE LYMPHOMA; MELANOMA; METASTASIS; PROTON THERAPY; RADIATION SHIELD; RELATIVE BIOLOGIC EFFECTIVENESS; RETINOBLASTOMA; SQUAMOUS CELL CARCINOMA; TARGET ORGAN; TRANSPUPILLARY THERMOTHERAPY; UVEA MELANOMA; VITREOUS BODY; X RAY;

EID: 84874071101     PISSN: 0950222X     EISSN: 14765454     Source Type: Journal    
DOI: 10.1038/eye.2012.241     Document Type: Conference Paper

References (45)

1. Hall E. Radiobiology for the Radiologist. 5th edn. Lippincott, Williams & Wilkins: Philadelphia, 2000
2. Moore RF. Choroidal sarcoma treated by the intraocular insertion of radon seeds. Br J Ophthalmol 1930;14: 145-156
3. Moore RF, Stallard HB, Milner JG. Retinal gliomata treated by radon seeds. Br J Ophthalmol 1931;15: 673-696
4. Stallard HB. Radiotherapy of intraocular neoplasms. Br J Ophthalmol 1948;32: 619-639
5. Stallard HB. Radiotherapy for malignant melanoma of the choroid. Br J Ophthalmol 1966;50: 147-155
6. Lommatsch PK, Volmer R. Ein neuerWeg zur konservativen Therapie intraokularerTumoren mit Betestrahlen (106Ru/106Rh) unter Erhaltung der Sehfahigkeit. Klin Monatsbl Augenheilkd 1966;148: 682-699
7. Sealy R, le Roux PLM, Rapley F, Hering E, Shackleton D, Sevel D. Treatment of ophthalmic tumours with low-energy sources. Br J Radiol 1976;49: 551-554
8. Lecuona K, Stannard C, Hart G, Myer L, Wetter J. The treatment of squamous carcinoma of the conjunctiva with beta irradiation. Presented at the International Society of Ocular Oncology (ISOO) meeting. Cambridge: England. 8-12 September 2009
9. Damato B, Coupland SE. An audit of conjunctival melanoma treatment in Liverpool. Eye 2009;23: 801-809
10. Brualla L, Zaragoza FJ, Sempau J, Wittig A, Sauerwein W. Electron irradiation of conjunctival lymphoma. Monte Carlo simulation of the minute dose distribution and technique optimization. Int J Radiat Oncol Biol Phys 2012;83: 1330-1337
11. Goda JS, Le LW, Lapperriere NJ, Millar BA, Payne D, Gospodarowicz MK et al. Localised orbital mucosaassociated lymphoma managed with primary radiation therapy: Efficacy and toxicity. Int J Radiat Oncol Biol Phys 2011;81: E659-e666
12. Hata M, Omura M, Koike I, Tomita N, Iijima Y, Tayama Yet al. Treatment effects and sequelae of radiation therapy for orbital mucosa-Associated lymphoid tissue lymphoma. Int J Radiat Oncol Biol Phys 2011;81: 1387-1393
13. Chauvel P, Caujolle JP, Sauerwein W, Friedrichs W, Brassart N, Herault J. Proton therapy as a possible salvage treatment for conjunctival melanomas. In: Frezzotti R, Balestrazzi E, Falco L (eds) Intraocular and Epibulbar Tumors. Monduzzi Editore: Bologna, 1994, pp 177-181
14. Sauerwein W, Stannard CE. Auge und Orbita. In: Bamberg M, Molls M, Sack H (eds) Radioonkologie Band 2: Klinik, W. Zuckschwerdt Verlag München Wien: New York, 2009, pp 294-316
15. Wuestemeyer H, Sauerwein W, Meller D, Chauvel P, Schueler A, Steuhl KP et al. Proton radiotherapy as an alternative to exenteration in the management of extended conjunctival melanoma. Graefes Arch Clin Exp Ophthalmol 2006;244: 438-446
16. Stannard CE, Sealy GRH, Hering ER, Pereira SB, Knowles R, Hill JC. Malignant melanoma of the eyelid and palpebral conjunctiva treated with I-125 brachytherapy. Ophthalmology 2000;107: 951-958
17. Shields CL, Shields JA, Cater J, Othmane I, Singh AD, Micaily B. Plaque therapy for retinoblastoma. Long term tumour control and treatment complications in 208 tumors. Ophthalmology 2001;198: 2116-2121
18. Stannard C, Sealy R, Shackleton D, Hill J, Korrubel J. The use of I-125 plaques in the treatment of retinoblastoma. Ophthalmic Paediatr Genet 1987;8: 89-93
19. Schueler AO, Fluhs D, Anastassiou G, Jurklies C, Neuhauser M, Schilling H et al. b-ray brachytherapy with Ru-106 plaques for retinoblastoma. Int J Radiat Oncol Biol Phys 2006;65: 1212-1221
20. Schipper J. An accurate and simple method for megavoltage radiation therapy of retinoblastoma. Radiother Oncol 1983;1: 31-41
21. Toma NMG, Hungerford JL, Plowman PN, Kingston JE, Doughty D. External beam radiotherapy for retinoblastoma: II. Lens sparing technique. Brit J Ophthalmol 1995;79: 112q-117q.
22. Messmer E, Sauerwein W, Heinrich T, Hopping W, Klueter-Reckmann D, Bornfeld N et al. New and recurrent tumor foci following local treatment as well as external beam radiation in eyes of patients with hereditary retinoblastoma. Graefe's Arch Clin Exp Ophthalmol 1990;228: 426-431
23. Krengli M, Hug EB, Adams JA, Smith AR, Tarbell NJ, Munzenrider JE. Proton radiation therapy for retinoblastoma: Comparison of various intraocular tumour locations and beam arrangements. Int J Radiat Oncol Biol Phys 2005;61: 583-593
24. StannardC, Sealy R, Hering E, Korrubel J, Hill J, BarronAet al. Localised whole eye radiotherapy for retinoblastoma using an I-125 applicator, 'Claws'. Int J Radiat Oncol Biol Phys 2001;51: 399-409
25. Stannard C, Hering E, Lecuona K, Maree G, Munro R, Davidson A. Localised whole eye therapy for retinoblastoma using an iodine-125 applicator, 'claws'. Presented at the International Congress of Ocular Oncology (ICOO). Siena, Italy. 25-30 June 2007
26. Stannard C, Sealy R, Hering E, Hough J, Knowles R, Lecuona K et al. Postenucleation orbits in retinoblastoma: Treatment with I-125 brachytherapy. Int J Radiat Oncol Biol Phys 2002;54: 1446-1454
27. Stannard C, Maree G, Munro R, Lecuona K, Sauerwein W. Iodine-125 orbital brachytherapy with a prosthetic implant in situ. Strahlenther Onkol 2011;187: 322-327
28. Shields CL, Naseripour M, Shields JA, Freire J, Cater J. Custom-designed plaque radiotherapy for non-resectable iris melanoma in 38 patients: Tumour control and ocular complications. Am J Ophthalmol 2003;85: 648-656
29. The Collaborative Ocular Melanoma Study Group. Design and methods of a clinical trial for a rare condition: The Collaborative Ocular Melanoma Study. COMS report no. 3 Control Clin Trials 1993;14: 362-373
30. Finger P T, Berson A, Ng T, Szechter A. Palladium-103 plaque radiotherapy for choroidal melanoma: An 11 year study. Int J Radiat Oncol Biol Phys 2002;54: 1438-1445
31. Char D H, Castro J R, Quivey J M, Phillips T L, Irvine A R, Stone RD et al. I-125 brachytherapy versus helium ion irradiation. Ophthalmology 1989;96: 1708-1715
32. Packer S, Stoller S, Lesser M L, Mandel F S, Finger PT. Long term results of iodine-125 irradiation of uveal melanoma. Ophthalmology 1992;99: 767-774
33. Fontanesi J, Meyer D, Xu S, Tai D. Treatment of choroidal melanoma with I-125 plaque. Int J Radiat Oncol Biol Phys 1993;26: 619-623
34. Wilson M, Hungerford J. Comparison of episcleral plaque therapy and proton beam radiation therapy for the treatment of choroidal melanoma. J Ophthalmol 1999;106: 1579
35. Shields C, Naseripour M, Cater J, Shields J A, Demirci H, Youseff A et al. Plaque radiotherapy for large posterior uveal melanomas (X8 mm thick) in 354 consecutive patients. Ophthalmology 2002;109: 1838-1849
36. Kivela T, Puusaari I, Damato B. Transscleral resection versus iodine brachytherapy for choroidal malignant melanoma 6 millimeters or more in thickness: A matched case-control study. Ophthalmology 2003;110: 2235-2244
37. Damato B. Adjunctive plaque radiotherapy after local resection of uveal melanoma. Front Radiat Ther Oncol 1997;30: 123-132
38. Egger E, Zografos L, Schalenbourg A, Beati D, Boehringer T, Chamot L. Eye retention after proton beam radiotherapy for uveal melanoma. Int J Radiat Oncol Biol Phys 2003;55: 867-880
39. Dendale R, Lumbroso-Le Rouic I, Noel G, Feuvret L, Levy C, Delacroix S et al. Proton beam radiotherapy for uveal melanoma;results of Curie Institute-Orsay Proton Therapy Centre (ICPO). Int J Radiat Oncol Biol Phys 2006;65: 780-787
40. Gragoudas E, Wenjun U, Goitein M, Lane A M, Munzenrider J E, Egan KE. Evidence-based estimates of outcome in patients irradiated for intraocular melanoma. Arch Ophthalmol 2002;120: 1665-1671
41. Dunavoelgyi R, Dieckmann K, Gleiss A, Sacu S, Kircher K, Georgopoulos M et al. Local tumour control, visual acuity and survival after hypofractionated stereotactic photon radiotherapy of choroidal melanoma in 212 patients treated between 1997 and 2007. Int J Radiat Oncol Biol Phys 2011;81: 100-205
42. Aizman A, Finger P T, Shabto U, Szechter A, Berson A. Palladium-103 (103Pd) plaque radiation therapy for circumscribed choroidal hemangioma with retinal detachment. Arch Ophthalmol 2004;122: 1652-1656
43. Zografos L, Egger E, Bercher L, Chamot L, Munkel G. Proton beam irradiation of choroidal hemangioma. Am J Ophthalmol 1998;126: 261-268
44. Levy-Gabriel C, Rouic L L, Plancher C, Dendale R, Delacroix S, Assetain B et al. Long-Term results of low dose proton beam therapy for circumscribed choroidal hemangioma. Retina 2009;29: 170-175
45. Ritland J S, Eide N, Tausjo J. External beam irradiation therapy for choroidal haemangioma. Visual and anatomic results after a dose of 20-25 Gy. Acta Ophthalmol Scand 2001;79: 184-186